コンテンツへスキップ
Merck

Epidural optogenetics for controlled analgesia.

Molecular pain (2016-04-01)
Robert P Bonin, Feng Wang, Mireille Desrochers-Couture, Alicja Ga Secka, Marie-Eve Boulanger, Daniel C Côté, Yves De Koninck
要旨

Optogenetic tools enable cell selective and temporally precise control of neuronal activity; yet, difficulties in delivering sufficient light to the spinal cord of freely behaving animals have hampered the use of spinal optogenetic approaches to produce analgesia. We describe an epidural optic fiber designed for chronic spinal optogenetics that enables the precise delivery of light at multiple wavelengths to the spinal cord dorsal horn and sensory afferents. The epidural delivery of light enabled the optogenetic modulation of nociceptive processes at the spinal level. The acute and repeated activation of channelrhodopsin-2 expressing nociceptive afferents produced robust nocifensive behavior and mechanical sensitization in freely behaving mice, respectively. The optogenetic inhibition of GABAergic interneurons in the spinal cord dorsal horn through the activation of archaerhodopsin also produced a transient, but selective induction of mechanical hypersensitivity. Finally, we demonstrate the capacity of optogenetics to produce analgesia in freely behaving mice through the inhibition of nociceptive afferents via archaerhodopsin. Epidural optogenetics provides a robust and powerful solution for activation of both excitatory and inhibitory opsins in sensory processing pathways. Our results demonstrate the potential of spinal optogenetics to modulate sensory behavior and produce analgesia in freely behaving animals.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
抗NeuN抗体、クローンA60, clone A60, Chemicon®, from mouse
Sigma-Aldrich
抗カルシトニン遺伝子関連ペプチド ウサギ宿主抗体, whole antiserum
Sigma-Aldrich
Anti-Glutamate Decarboxylase 65 & 67 Antibody, Chemicon®, from rabbit